Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficient Nanovaccine Delivery in Cancer Immunotherapy

9 Mar 2017

Abstract excerpt

Vaccines hold tremendous potential for cancer immunotherapy by treating the immune system. Subunit vaccines, including molecular adjuvants and cancer-associated antigens or cancer-specific neoantigens, can elicit potent antitumor immunity. However, subunit vaccines have shown limited clinical benefit in cancer patients, which is in part attributed to inefficient vaccine delivery. In this Perspective, we discuss...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28277646
DOI: 10.1021/acsnano.7b00978

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficient Nanovaccine Delivery in Cancer ImmunotherapyPMID 28277646Read ↗

Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapySemantic proximity Read ↗

Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen LoadingSemantic proximity Read ↗

Eliciting B cell immunity against infectious diseases using nanovaccines.Semantic proximity Read ↗

Genetically Engineered Cytomembrane Nanovaccines for Cancer ImmunotherapySemantic proximity Read ↗

“Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer ImmunotherapySemantic proximity Read ↗

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trendsSemantic proximity Read ↗

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read ↗

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunitySemantic proximity Read ↗

Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer ImmunotherapySemantic proximity Read ↗

Nanomedicine for Cancer and Autoimmune ImmunotherapySemantic proximity Read ↗

mRNA vaccines: a new era in vaccine developmentSemantic proximity Read ↗

Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-mediated Tumor ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.